2024 World Transfusion Diagnostic Analyzers and Reagent Market Forecasts for 40 Immunohematology and NAT Assays: Americas, EMEA, APAC--A 90-Country Analysis--Supplier Shares and Strategies, Latest Technologies and Instrumentation
This new 90-country report is available by region, country, market segment, section, or individual test.
The report is available by section, and can be customized to specific information needs and budget.
The report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the global blood banking market during the next five years, and assist industry executives in developing effective business, new product development and marketing strategies.
The report explores future market and technological trends; provides test volume and sales forecasts by market segment/test location; compares features of major automated and semi-automated molecular and immunohematology analyzers; profiles leading and emerging competitors; and identifies specific product and market opportunities facing suppliers during the next five years.
Blood Group Genotyping
PCR, PCR-RFLP, AS-PCR or PCR-SSP, Multiplex PCR, Real Time PCR, Sanger DNA Sequencing, Pyrosequencing
Microarrays
BeadChip Array, BloodChip, Genome Lab SNP Stream, Fluidic Microarray Systems, TaqMan OpenArray, MALDI-TOF-MS, Mini-Sequencing
Blood Typing and Grouping Tests
ABO, Antibody Panels, Antibody Screening/Indirect Antiglobulin, Antigen Typing (C, c, Duffy, E, e, I, i, Kell, Kidd, Le a, b, MN, P, S, s), Antiglobulin (Direct, C3 + IgG, IgG, C3), Crossmatching (Immediate Spin, Full Crossmatch), Rh (D, Du).
Infectious Disease Screening Tests
AIDS (HIV NAT, HIV-1/2), Cytomegalovirus, Hepatitis (HAV NAT, HBV NAT, HBs Ag, Anti-HBc, HCV NAT, HCV, ALT/SGPT), HTLV-I/II, Parvovirus B19 NAT, Syphilis, West Nile Virus NAT.
Sales and Market Share Analysis
Sales and market share estimates for leading suppliers of blood typing, grouping and infectious disease screening tests in major countries.
Geographic Regions
Asia-Pacific, Europe, Latin America, Middle East, North America
Country Analyses
Albania, Argentina, Australia, Austria, Bahrain, Bangladesh, Belarus, Belgium, Bolivia, Brazil, Bulgaria, Canada, Chile, China, Colombia, Costa Rica, Croatia, Cuba, Cyprus, Czech Republic, Denmark, Dominican Republic, Ecuador, El Salvador, Estonia, Finland, France, Georgia, Germany, Greece, Guatemala, Haiti, Honduras, Hong Kong, Hungary, Iceland, India, Indonesia, Iran, Iraq, Ireland, Israel, Italy, Jamaica, Japan, Jordan, Kazakhstan, Kuwait, Latvia, Lebanon, Lithuania, Malaysia, Malta, Mexico, Moldova, Myanmar, Netherlands, New Zealand, Nicaragua, Norway, Oman, Pakistan, Panama, Paraguay, Peru, Philippines, Poland, Portugal, Puerto Rico, Qatar, Romania, Russia, Saudi Arabia, Serbia, Singapore, Slovakia, Slovenia, South Korea, Spain, Sweden, Switzerland, Taiwan, Thailand, UK, Ukraine, United Arab Emirates, Uruguay, USA, Venezuela, Vietnam
Competitive Assessments
Strategic assessments of major suppliers and emerging market entrants, including their sales, M&A, product portfolios, marketing tactics, and new products in R&D.
Market Segmentation Analysis
- Comprehensive market segmentation analysis, including review of the market dynamics, trends, structure, size, growth, and key suppliers.
- Test volume and sales forecasts for over 40 blood typing, grouping and infectious disease screening tests, including NAT assays.
Current and Emerging Products
- Analysis of current and emerging molecular blood typing, grouping and infectious disease NAT screening assays.
- Review of automated and semi-automated molecular and immunohematology analyzers.
Technology Review
- Assessment of current and emerging technologies, and their potential applications for the blood banking market.
- Companies developing or marketing new technologies and products, by test.
Strategic Recommendations
- New product development opportunities for molecular blood typing, grouping and infectious disease NAT assays and instrumentation with significant market appeal.
- Alternative market penetration strategies.
- Potential market entry barriers and risks.
I. Introduction
II. Worldwide Market Overview
A. Business Environment
B. Market Structure
III. Major Product Development Opportunities
A. Blood Typing and Grouping
B. Infectious Disease Screening
C. Auxiliary
IV. Alternative Market Penetration Strategies
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
V. Potential Market Entry Barriers and Risks
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
VI. Worldwide Technology and Market Overview
A. Major Blood Typing, Grouping and Infectious
Disease Screening Tests
1. Blood Typing and Grouping Tests
a. ABO
b. Antibody Panels
c. Antibody Screening
d. Antigen Typing
e. Antiglobulin Test
f. Crossmatch
g. HLA Typing
h. Rh
i. Other Blood Groups
2. Infectious Disease Screening Tests
a. AIDS/HIV
- Background
- Diagnostic Tests
Enzyme Immunoassay
Viral Load/Drug Resistance Testing
Genotype and Phenotype Testing
- Blood Banking Considerations
b. Hepatitis Markers
- Hepatitis A
- Hepatitis B
- Hepatitis C
- Hepatitis D (Delta Hepatitis)
- Hepatitis E
- Hepatitis G
- Vaccines and Drugs
c. Cytomegalovirus
- Background
- Diagnostic Tests
- Vaccines and Drugs
d. Syphilis
- Background
- Diagnostic Tests
- Vaccines and Drugs
e. West Nile Virus
- Background
- Clinical Syndromes
- Diagnostic Tests
- Vaccines and Drugs
f. Parvovirus B19
- Microbiology
- Epidemiology
- Clinical Syndromes
- Diagnostic Test
- Vaccines and Drugs
g. Creutzfeldt-Jakobs Disease
- Background
- Transmission
- Diagnostic Tests
- Vaccines and Drugs
h. Malaria
i. Chagas Disease
j. Babesiosis
3. Pathogen Reduction
4. Leukocyte Reduction
- Background
- Methods
B. Instrumentation Review: Operating Characteristics,
Features and Selling Prices of Leading Blood Typing, Grouping
And Infectious Disease Screening Automated and Semiautomated Analyzers
C. Major Blood Banking Technologies and Their Potential Applications
1. Molecular Diagnostics
2. Monoclonal and Polyclonal Antibodies
3. Immunoassays
4. Microtitration Plates
5. IT and Automation
6. Lasers
7. Robotics
8. Synthetic Red Cell Substitutes
9. Genetically Engineered Blood Components
10. Blood Preservation
11. Autologous Blood Transfusion/Freezing
VII. Country Market Analyses: Blood Typing, Grouping and Infectious Disease Screening Test
Volume and Sales Forecasts for 90 Countries:
Albania, Argentina, Australia, Austria, Bahrain, Bangladesh, Belarus, Belgium, Bolivia, Brazil, Bulgaria,
Canada, Chile, China, Colombia, Costa Rica, Croatia, Cuba, Cyprus, Czech Republic, Denmark,
Dominican Republic, Ecuador, El Salvador, Estonia, Finland, France, Georgia, Germany, Greece,
Guatemala, Haiti, Honduras, Hong Kong, Hungary, Iceland, India, Indonesia, Iran, Iraq, Ireland, Israel,
Italy, Jamaica, Japan, Jordan, Kazakhstan, Kuwait, Latvia, Lebanon, Lithuania, Malaysia, Malta,
Mexico, Moldova, Myanmar, Netherlands, New Zealand, Nicaragua, Norway, Oman, Pakistan,
Panama, Paraguay, Peru, Philippines, Poland, Portugal, Puerto Rico, Qatar, Romania, Russia, Saudi
Arabia, Serbia, Singapore, Slovak Republic, Slovenia, South Korea, Spain, Sweden, Switzerland,
Taiwan, Thailand, UK, Ukraine, United Arab Emirates, Uruguay, USA, Venezuela, Vietnam
VIII. Competitive Assessments
Abbott
Beckman Coulter/Danaher
Becton Dickinson
Biokit
bioMerieux
Bio-Rad
Diagast
DiaSorin
Fujirebio
Grifols
Hologic
Immucor
LabCorp
Ortho-Clinical Diagnostics
Proteome Sciences
Quest Diagnostics
Quidel
Roche
Siemens Healthineers
Tecan
Thermo Fisher
2024 Italy Hospital Tumor Marker Testing Market Supplier Shares by Test and Strategies Volume and Sales Segment Forecasts Technology and Instrumentation Review Emerging Opportunities
2024 Italy Hospital Tumor Marker Testing Market: Supplier Shares by Test and Strategies, Volume and Sales Segment Forecasts, Technology and Instrumentation Review, Emerging Opportunities This new report from contains 525
USD 3450 View Report2024 Germany Hospital Tumor Marker Testing Market Supplier Shares by Test and Strategies Volume and Sales Segment Forecasts Technology and Instrumentation Review Emerging Opportunities
2024 Germany Hospital Tumor Marker Testing Market: Supplier Shares by Test and Strategies, Volume and Sales Segment Forecasts, Technology and Instrumentation Review, Emerging Opportunities This new report from contains 530
USD 3450 View Report2024 World Hospital Hemostasis Diagnostics Market Supplier Shares Country Emerging Tests Technology Trends Instrumentation Review Sales Forecasts
2024 World Hospital Hemostasis Diagnostics Market: Supplier Shares by Country, Emerging Tests, Technology Trends, Instrumentation Review, Sales Forecasts by Country, and Strategic Profiles of Leading Suppliers This new report from
USD 6500 View Report2024 World Coagulation Testing Market Countries
2024 World Coagulation Testing Market in 98 Countries--Hemostasis Analyzers and Consumables--2023 Supplier Shares, 2023-2028 Segment Volume and Sales Forecasts for over 40 Coagulation Assays, Opportunities for Suppliers--Molecular, Chromogenic and Immunodiagnostic
USD 28500 View ReportFill The Form For Sample Request